Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 20, 2023

BUY
$0.43 - $0.65 $21,500 - $32,500
50,000 Added 24.63%
253,000 $129,000
Q1 2023

May 09, 2023

BUY
$0.46 - $0.81 $4,600 - $8,100
10,000 Added 5.18%
203,000 $127,000
Q4 2022

Feb 14, 2023

BUY
$0.5 - $261.0 $17,500 - $9.14 Million
35,000 Added 22.15%
193,000 $125,000
Q3 2022

Oct 27, 2022

BUY
$1.04 - $322.5 $5,200 - $1.61 Million
5,000 Added 3.27%
158,000 $271,000
Q2 2022

Aug 09, 2022

BUY
$0.41 - $1.24 $10,250 - $31,000
25,000 Added 19.53%
153,000 $189,000
Q1 2022

May 05, 2022

BUY
$0.62 - $1.17 $15,500 - $29,250
25,000 Added 24.27%
128,000 $83,000
Q4 2021

Jan 25, 2022

BUY
$1.09 - $1.89 $54,500 - $94,500
50,000 Added 94.34%
103,000 $112,000
Q3 2021

Oct 12, 2021

BUY
$1.44 - $2.73 $30,240 - $57,330
21,000 Added 65.63%
53,000 $96,000
Q2 2021

Aug 05, 2021

BUY
$2.63 - $3.67 $13,150 - $18,350
5,000 Added 18.52%
32,000 $84,000
Q4 2020

Jan 21, 2021

SELL
$2.09 - $3.09 $4,702 - $6,952
-2,250 Reduced 7.69%
27,000 $68,000
Q3 2020

Oct 14, 2020

BUY
$2.39 - $3.43 $11,950 - $17,150
5,000 Added 20.62%
29,250 $73,000
Q2 2020

Aug 13, 2020

SELL
$2.2 - $3.71 $8,800 - $14,840
-4,000 Reduced 14.16%
24,250 $79,000
Q1 2020

Apr 17, 2020

BUY
$1.9 - $4.98 $8,075 - $21,165
4,250 Added 17.71%
28,250 $69.2 Million
Q4 2019

Jan 13, 2020

BUY
$3.95 - $5.35 $9,875 - $13,375
2,500 Added 11.63%
24,000 $113,000
Q4 2018

Jan 31, 2019

BUY
$1.61 - $3.62 $34,615 - $77,830
21,500 New
21,500 $40,000

Others Institutions Holding TCRT

About Alaunos Therapeutics, Inc.


  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $458M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Allred Capital Management, LLC Portfolio

Follow Allred Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allred Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allred Capital Management, LLC with notifications on news.